Delisting risk
China SXT Pharmaceuticals (SXTC)
Manufacturer of Suxuantang traditional Chinese medicine pieces for Chinese hospitals, wholesalers and pharmacy chains.
$2.28
Pre-market+0.05 (+2.24%)
At close$2.23(−9.35%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions3 holders · as of Mar 31, 2026 | 0.17% | 977 ADS | |
| Insiders1 holder · as of Apr 27, 2026 | — | 0 ADS |
institutions as of Mar 31, 2026 · holders as of their latest filing
The share count is from the company's Mar 2021 annual report; nothing newer is on file here.
No reliable share count is available for this listing, so stakes are shown as shares, not percentages.
A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.
The institutional percentage is the one reported with the filings, not one recomputed on the share count here.
Institutions13F, as of Mar 31, 2026
3 holders · 78.2K shares
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Sabby Management, LLC | 78.2K | May 15, 2026 | ||
| UBS Group AG | 1 | May 5, 2026 | ||
| Caitong International Asset Management Co., Ltd | 1 | May 11, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Foong Soon Hong, Randy | 9.12% | 13G | Aug 7, 2025 ↗ | |
| Tan Soo Seng | 8.95% | 13G | Aug 7, 2025 ↗ | |
| Tan Cheng Guan | 8.79% | 13G | Aug 7, 2025 ↗ | |
| Ching Choon Hwa | 8.45% | 13G | Aug 7, 2025 ↗ |
Insider tradesForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.
